Park Square Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$144K Sell
120
-5
-4% -$5.11K 1.3% 21
2026
Q1
$115K Sell
125
-11
-8% -$11.2K 0.87% 20
2025
Q4
$105K Sell
136
-1
-0.7% -$956 0.62% 20
2025
Q3
$105K Sell
137
-1,356
-91% -$1.01M 0.45% 23
2025
Q2
$1.16M Buy
1,493
+29
+2% +$22.5K 0.84% 24
2025
Q1
$1.21M Sell
1,464
-113
-7% -$94K 0.96% 24
2024
Q4
$1.22M Buy
+1,577
New +$1.31M 0.84% 26

Other funds holding LLY

Park Square Financial Group's LLY Position: Q2 2026 in Review

Park Square Financial Group reduced its Eli Lilly (LLY) stake by 4% in Q2 2026, selling an estimated $5.11K and leaving 120 shares worth $144K. The position accounts for 1.3% of the portfolio, ranked #21.

Park Square Financial Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.22M in Q4 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Park Square Financial Group held 120 shares of Eli Lilly worth $144K as of Q2 2026.
  • Park Square Financial Group sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 1.3% of Park Square Financial Group's portfolio in Q2 2026, its #21 holding.
  • Park Square Financial Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Park Square Financial Group's Eli Lilly position peaked at $1.22M in Q4 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Park Square Financial Group's 13F filing for Q2 2026, filed 31 Jul 2026.